Get the Stockscreener App
1.2099
1.63%
-0.0151
Oragenics Inc stock is traded at $1.2099, with a volume of 37,218.
It is down -1.63% in the last 24 hours and down -8.02% over the past month.
Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$1.225
Open:
$1.23
24h Volume:
37,218
Relative Volume:
0.26
Market Cap:
$4.99M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.1417
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
-9.40%
1M Performance:
-8.02%
6M Performance:
-79.39%
1Y Performance:
-86.47%
1-Day Range:
$1.19
$1.23
1-Week Range:
$1.19
$1.34
52-Week Range:
$1.01
$18.90
Oragenics Inc Stock (OGEN) Company Profile
Name
Oragenics Inc
Sector
Industry
Phone
813-286-7900
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.2094 | 5.06M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.80 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.61 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.11 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oragenics Inc Stock (OGEN) Latest News
What technical charts say about Oragenics Inc. stockTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
Why Oragenics Inc. stock is recommended by analysts2025 Investor Takeaways & Community Consensus Trade Signals - newser.com
Is Oragenics Inc. stock a top momentum playPortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com
Sector ETF performance correlation with Oragenics Inc.Trade Risk Summary & Fast Exit and Entry Strategy Plans - newser.com
How Oragenics Inc. stock performs in weak economyJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
Will Oragenics Inc. stock maintain momentum in 20252025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
Oragenics Inc. stock outlook for YEARJuly 2025 Rallies & Stepwise Entry/Exit Trade Alerts - newser.com
What MACD trends signal for Oragenics Inc. stockGap Up & High Accuracy Investment Entry Signals - newser.com
Full technical analysis of Oragenics Inc. stockQuarterly Portfolio Report & High Accuracy Buy Signal Tips - newser.com
Why Oragenics Inc. stock appears on watchlistsPortfolio Return Report & Fast Gain Swing Trade Alerts - newser.com
Why Oragenics Inc. stock is popular among millennialsJuly 2025 Update & Technical Buy Zone Confirmation - newser.com
Is Oragenics Inc. stock cheap at current valuation2025 Earnings Impact & Short-Term Trading Opportunity Alerts - newser.com
Can you recover from losses in Oragenics Inc.July 2025 Sector Moves & Safe Swing Trade Setups - newser.com
Is Oragenics Inc. trending in predictive chart models2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
Will Oragenics Inc. stock outperform value stocks2025 Analyst Calls & Weekly Top Gainers Alerts - newser.com
Is Oragenics Inc. stock near bottom after declineJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
What analysts say about Oragenics Inc stockMoving Average Strategies & Free Extraordinary Earning Power - earlytimes.in
Why Oragenics Inc. stock is seen as undervalued2025 Key Highlights & Smart Money Movement Alerts - newser.com
Combining machine learning predictions for Oragenics Inc.July 2025 Selloffs & Verified Momentum Stock Ideas - newser.com
Heatmap analysis for Oragenics Inc. and competitorsWeekly Trend Recap & Community Trade Idea Sharing Platform - newser.com
Analyzing Oragenics Inc. with multi timeframe chartsJuly 2025 Snapshot & Target Return Focused Picks - newser.com
Published on: 2025-10-31 05:02:48 - newser.com
What the charts say about Oragenics Inc. todayTrade Entry Report & Low Drawdown Momentum Trade Ideas - newser.com
Oragenics Inc Stock (OGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):